RheOx™ for Chronic Bronchitis

RheOx™ for Chronic Bronchitis.  The RheSolve Study

ClinicalTrials.gov identifier NCT04677465

Chronic Bronchitis affects millions of adults worldwide, causing symptoms such as: chronic cough, trouble breathing, and chest tightness. Right now, doctors at our research center are conducting a new research study of Bronchial Rheoplasty using RheOx™, an investigational device designed to reduce cough and mucus production through a minimally-invasive procedure.

SELECTED ELIGIBILITY CRITERIA

• Age 35 or older
• Have smoked for at least 10 years
• Have been tobacco free for at least 6 months
• Have significant cough and phlegm
• Have no previous lung surgery

Study participants will be compensated for study visits, including phone visits. Please speak to your study coordinator about any needed transportation accommodations.

Frequently Asked Questions

Please contact us to learn more.

For Clinical Trial Recruitment

Study Sponsor: Gala Therapeutics

Make an appointment for a private evaluation, at no cost to you, at our research center located on the campus of Harbor/UCLA Medical Center in Torrance, CA